Reaction
Mitral Valve Calcification reporting signals
As of the last recalculation, Mitral Valve Calcification appears in 637 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is EPLERENONE (PRR 60.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eplerenone | 23 | 60.8 | 61.0 |
| Digoxin | 85 | 44.5 | 44.6 |
| Atropine | 10 | 40.1 | 40.1 |
| Chlorhexidine Gluconate | 11 | 40.0 | 40.1 |
| Enalapril Maleate | 25 | 34.3 | 34.3 |
| Diltiazem Hydrochloride | 32 | 31.8 | 31.8 |
| Atropine Sulfate | 10 | 30.7 | 30.7 |
| Metolazone | 9 | 26.5 | 26.5 |
| Losartan Potassium And Hydrochlorothiazide | 9 | 25.7 | 25.7 |
| Dapagliflozin | 22 | 23.6 | 23.7 |
| Exemestane | 14 | 21.8 | 21.8 |
| Dorzolamide Hydrochloride And Timolol Maleate | 5 | 20.8 | 20.8 |
| Paricalcitol | 7 | 16.4 | 16.4 |
| Inclisiran | 3 | 12.3 | 12.3 |
| Cinacalcet Hydrochloride | 6 | 4.2 | 4.2 |